India Equity Analyst - Fundamental & Thematic, Beat the Street

Sudarshan Bhandari

India Equity Analyst - Fundamental & Thematic

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

Equity Bottom-Up

<ul>
<li>Acutaas is successfully pivoting from pure-play pharmaceuticals into high-growth sectors like battery electrolytes and semiconductors, becoming the first non-Chinese player to innovate these additives at scale.</li>
<li>Leveraging the "China Plus One" shift and US regulations (IRA), the company secures a premium by offering a protected supply chain immune to geopolitical trade risks.</li>
<li>Backward integration and green technologies drive cost leadership, while long-term contracts with pass-through clauses shield margins from input price volatility, ensuring sustainable profitability.</li>
</ul>


Acutaas is successfully pivoting from pure-play pharmaceuticals into high-growth sectors like battery electrolytes and semiconductors, becoming the first non-Chinese player to innovate these additives at scale.
Leveraging the "China Plus One" shift and US regulations (IRA), the company secures a premium by offering a protected supply chain immune to geopolitical trade risks.
Backward integration and green technologies drive cost leadership, while long-term contracts with pass-through clauses shield margins from input price volatility, ensuring sustainable profitability.


Acutaas Chemicals: Transforming Chemistry into High-Tech Solutions

Thematic (Sector/Industry)

<ul>
<li>With Nifty 50 earnings growth barely 3% YoY in CY25, companies that voluntarily offer specific, multi-metric guidance signal not just confidence, but accountability. </li>
<li>Management-Backed targets are a meaningful filter in a market where execution risk dominates.</li>
<li>Twenty Indian mid and small-cap companies have issued explicit quantitative growth guidance for FY26–FY27, spanning revenue, EBITDA, and AUM metrics across sectors from specialty chemicals to power systems to CRDMO.</li>
</ul>


With Nifty 50 earnings growth barely 3% YoY in CY25, companies that voluntarily offer specific, multi-metric guidance signal not just confidence, but accountability. 
Management-Backed targets are a meaningful filter in a market where execution risk dominates.
Twenty Indian mid and small-cap companies have issued explicit quantitative growth guidance for FY26–FY27, spanning revenue, EBITDA, and AUM metrics across sectors from specialty chemicals to power systems to CRDMO.


India's Guided Growth Playbook: 20 Companies Telling You Exactly Where They're Going

Forensic Analyst, Trudence Capital Advisors

Nitin Mangal

Forensic Analyst

Trudence Capital Advisors

Trudence Capital Advisors Private Limited is a SEBI-registered Research Analyst, holding SEBI registration number INH000015747. Our firm is dedicated to providing independent and unbiased research on Indian mid to large-cap companies. Trudence Capital is known for its counter-consensus views, with a focus on forensic research and on-ground primary investigations. Our research approach is thorough, involving detailed analysis of accounting practices and governance, alongside extensive channel checks.

Independent & Unbiased Research

Forensic Accounting

<ul>
<li>
<a href="https://www.smartkarma.com/entities/ami-organics-ltd" target="_blank" data-smartkarma-citation="entities:34235:1" rel="noopener">AMI Organics Ltd (AMIORG IN)</a>  is engaged in business of drugs intermediate chemicals and related activities.</li>
<li>Key forensic takeaways include bizarre accounting especially pertaining to JV, no provisioning on debtors and working capital woes, and mystery towards transfer from CWIP.</li>
<li>There are governance related concerns surrounding related parties, churn in top management, etc that should also not be overlooked.</li>
</ul>



AMI Organics Ltd (AMIORG IN)  is engaged in business of drugs intermediate chemicals and related activities.
Key forensic takeaways include bizarre accounting especially pertaining to JV, no provisioning on debtors and working capital woes, and mystery towards transfer from CWIP.
There are governance related concerns surrounding related parties, churn in top management, etc that should also not be overlooked.


India

Acutaas Chemicals Limited operates as a managed pharmaceutical company. The Company specializes in pharmaceuticals research and development, custom synthesis, and contract manufacturing. Acutaas Chemicals serves customers in India.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Acutaas Chemicals (ACUTAAS IN)

Acutaas Chemicals: Transforming Chemistry into High-Tech Solutions

Acutaas transitions from pharmaceuticals to high-growth sectors, leading in battery electrolytes and semiconductors as the first non-Chinese player.

Sudarshan Bhandari

India's Guided Growth Playbook: 20 Companies Telling You Exactly Where They're Going

These are 20 Indian Companies offering specific, multi-metric guidance signal confidence and accountability in a market dominated by execution risk.

Sudarshan Bhandari

Ami Organics Ltd: Forensic Analysis

Key forensic takeaways include bizarre accounting especially pertaining to JV, no provisioning on debtors and working capital woes, and mystery...

Nitin Mangal

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Acutaas Chemicals: Transforming Chemistry into High-Tech Solutions

​Acutaas transitions from pharmaceuticals to high-growth sectors, leading in battery electrolytes and semiconductors as the first non-Chinese player.

Sudarshan Bhandari

India's Guided Growth Playbook: 20 Companies Telling You Exactly Where They're Going

​These are 20 Indian Companies offering specific, multi-metric guidance signal confidence and accountability in a market dominated by execution risk.

Sudarshan Bhandari

Ami Organics Ltd: Forensic Analysis

Key forensic takeaways include bizarre accounting especially pertaining to JV, no provisioning on debtors and working capital woes, and mystery...

Nitin Mangal

Acutaas transitions from pharmaceuticals to high-growth sectors, leading in battery electrolytes and semiconductors as the first non-Chinese player.

These are 20 Indian Companies offering specific, multi-metric guidance signal confidence and accountability in a market dominated by execution risk.